COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study to Validate Simple Acute Coronary Syndrome Score (SACS Score)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00947804
Recruitment Status : Unknown
Verified December 2012 by Wayne Ruppert, St. Joseph's Hospital, Florida.
Recruitment status was:  Enrolling by invitation
First Posted : July 28, 2009
Last Update Posted : April 8, 2013
Information provided by (Responsible Party):
Wayne Ruppert, St. Joseph's Hospital, Florida

Brief Summary:

The Simple Acute Coronary Syndrome (SACS) Score was developed as a Risk Stratification Tool for Acute Coronary Syndrome (ACS). It is a tool which rates a patient's: SYMPTOMS, EKG FINDINGS, RISK FACTOR PROFILE, and CARDIAC MARKERS on a scale of zero to six.

The purpose of this study is to validate the SACS Scoring tool by establishing a correlation between the score's numerical values and the degree of obstructive cardiovascular disease visualized during cardiac catheterization.

Condition or disease
Acute Coronary Syndrome

Show Show detailed description

Layout table for study information
Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Phase 1 - Pilot Study to Validate the Simple Acute Coronary Syndrome Score; an Acute Coronary Syndrome (ACS) Risk Stratification Tool
Study Start Date : August 2009
Estimated Primary Completion Date : December 2013
Estimated Study Completion Date : June 2014

1. Patients with symptoms of ACS
Patients whom present emergently to the Cardiac Catheterization Lab with current symptoms of Acute Coronary Syndrome (ACS), whom at the time of admission to the cardiac catheterization lab are believed to be suffering from STEMI, NSTEMI, or Unstable Angina, with the possible need for emergency Percutaneous Coronary Intervention (PCI), or Coronary Artery Bypass Grafting (CABG).
2. Patients without symptoms of ACS
Non-emergency patients presenting to the Cardiac Catheterization Lab for elective coronary angiography, and possible PCI. These are patients whom may have experienced typical or atypical ACS symptoms intermittently, and have elected to have cardiac catheterization to rule out obstructive CAD. Patients in this group will be selected randomly, with consent obtained, prior to cardiac catheterization.

Primary Outcome Measures :
  1. PRESENCE or ABSENCE of obstructive CAD as discovered during non-investigative coronary angiography in the Cardiac Catheterization Lab. [ Time Frame: Within 24 hours of: a) arrival in Emergency Department, or b) admission to the hospital ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Adult patients presenting to the cardiac catherization suite whom have experienced ACS symptoms within the past thirty days.

Inclusion Criteria:

  • Must be mentally competent with ability to articulate symptoms and risk factor profile

Exclusion Criteria:

  • Renal disease
  • When unable to obtain all required data sets (SYMPTOMS, EKG, TIMI RISK FACTOR PROFILES, CARDIAC LABS)
  • EKG displays DELTA WAVES consistent with Wolff-Parkinson-White Syndrome

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00947804

Layout table for location information
United States, Florida
St. Joseph's Hospital
Tampa, Florida, United States, 33607
Sponsors and Collaborators
St. Joseph's Hospital, Florida
Layout table for investigator information
Principal Investigator: Wayne W Ruppert, CVT St. Joseph's Hospital, Tampa, FL
Study Director: Humberto Coto, MD, FACC St. Joseph's Hostpial, Tampa, Florida
Study Director: Xavier E Prida, MD, FACC St. Joseph's Hospital, Tampa, Florida
Study Director: Charles Sand, MD, FACEP St. Joesph's Hospital, Tampa, FL
Layout table for additonal information
Responsible Party: Wayne Ruppert, Principal Investigator, St. Joseph's Hospital, Florida Identifier: NCT00947804    
Other Study ID Numbers: ACS SACS Score SJH-01
First Posted: July 28, 2009    Key Record Dates
Last Update Posted: April 8, 2013
Last Verified: December 2012
Keywords provided by Wayne Ruppert, St. Joseph's Hospital, Florida:
Acute Coronary Artery Syndrome Risk Stratification Score
Additional relevant MeSH terms:
Layout table for MeSH terms
Acute Coronary Syndrome
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases